HLS HLS Therapeutics Inc
- 3.510
- -0.040-1.13%
HLS Therapeutics Inc News
Strategic Divestiture and Financial Flexibility: HLS Therapeutics Inc's Optimistic Buy Rating
Stifel Nicolaus Keeps Their Hold Rating on HLS Therapeutics Inc (HLS)
HLS Therapeutics Downgraded to Hold at Stifel GMP on Revenue Concerns; Price Target Cut to C$5.00
HLS Therapeutics Inc (HLS) Receives a Buy From Stifel Nicolaus
Bloom Burton Remains a Buy on HLS Therapeutics Inc (HLS)
Clarus Sticks to Its Buy Rating for HLS Therapeutics Inc (HLS)
HLS Therapeutics Inc (HLS) Gets a Buy Rating From Stifel Nicolaus
Stifel Nicolaus Remains a Buy on HLS Therapeutics Inc (HLS)
Stifel Nicolaus Keeps Their Buy Rating on HLS Therapeutics Inc (HLS)
Stifel Nicolaus Keeps Their Buy Rating on HLS Therapeutics Inc (HLS)
HLS Therapeutics Inc (HLS) Receives a Buy From Clarus
HLS Therapeutics Inc (HLS) Receives a Buy From Stifel Nicolaus
No Data